Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05833438
PHASE2

Venetoclax in Combination with 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy

Sponsor: University of Leipzig

View on ClinicalTrials.gov

Summary

Acute myeloid leukemia (AML): continuous oral Venetoclax (VEN) and 7 days of s.c. Azacitidine (AZA) per 28-day cycle = standard of care for intensive induction therapy ineligible AML patients in Germany The VENAZA-5S pilot trial: AZA administration reduced to 5 days within each cycle to improve tolerability and treatment adherence due to less neutropenic infections, less treatment interruptions and less hospitalizations.

Official title: A Single-arm, Pilot Study of Venetoclax in Combination with 5 Days Azacitidine in Treatment-naïve Subjects with Acute Myelogenous Leukemia Who Are ≥18 Years of Age and Not Eligible for Standard Induction Therapy (VENAZA-5S PILOT TRIAL)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2023-05-17

Completion Date

2025-07

Last Updated

2024-12-09

Healthy Volunteers

No

Interventions

DRUG

VEN+AZA-5

Up to 6 cycles: Azacitidine (AZA) 75 mg/m2, d1-5 of each 28 day cycle (SC) in combination with Venetoclax (VEN): 400 mg daily (orally)

Locations (10)

Helios Klinikum Berlin-Buch Klinik für Hämatologie und Stammzelltransplantation

Berlin, Germany

Klinikum Chemnitz gGmbH Klinik für lnnere Medizin Ill

Chemnitz, Germany

Carl-Thiem-Klinikum Cottbus gGmbH

Cottbus, Germany

Universitatsklinikum Carl Gustav Carus Dresden an der TU Dresden Medizinische Klinik und Poliklinik 1 Bereich Hamatologie

Dresden, Germany

Universitätsklinikum Heidelberg, Innere Medizin V; Klinik für Hämatologie, Onkologie und Rheumatologie

Heidelberg, Germany

Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie

Leipzig, Germany

Kliniken Maria Hilf GmbH, Klinik für Hämatologie, Onkologie und Gastroenterologie

Mönchengladbach, Germany

Rotkreuzklinikum München, III. Medizinische Abteilung

München, Germany

Klinikum rechts der lsar der TU München, Klinik und Poliklinik für lnnere Medizin Ill

München, Germany

Kliniken Sindelfingen,Medizinische Klinik I

Sindelfingen, Germany